Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-22

Clinical Trial Update: Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS). [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy and safety of Yuxuebi Tablet for ankylosing spondylitis, with current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yuxuebi Tablet

Snippet

Sponsor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 4 | Status: UNKNOWN